Photomedicine Market Report 2026

The photomedicine market size has grown strongly in recent years. It will grow from $4.95 billion in 2025 to $5.41 billion in 2026 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to limited availability of photomedicine devices, reliance on conventional treatment methods, increasing prevalence of skin and dental conditions, growing hospital and clinic infrastructure, rising awareness about non-invasive therapies.

The photomedicine market size is expected to see strong growth in the next few years. It will grow to $7.62 billion in 2030 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to advancements in led and laser technologies, increasing integration of wearable photomedicine devices, expansion of home-based therapy solutions, growing research in tissue regeneration applications, rising adoption of digital monitoring and remote therapy platforms. Major trends in the forecast period include rising adoption of light-based therapies in oncology and dermatology, growth in home-based photomedicine devices and therapy systems, increasing use of non-invasive pain management solutions, expansion of aesthetic and cosmetic photomedicine treatments, integration of photomedicine in dental and ophthalmic procedures.

The uptick in cosmetic surgeries is anticipated to fuel the photomedicine market moving forward. Cosmetic surgeries are elective operations to refine or modify appearance for beauty goals. Their increase ties to social media's sway and heightened quests for polished self-perception, driven by pervasive ideals and fads. Photomedicine aids cosmetic surgeries with accurate, minimally invasive options that refine skin, fade flaws, and elevate facial and body looks with little recovery time. For example, in April 2025, the British Association of Aesthetic Plastic Surgeons (BAAPS), a UK surgical body, logged 27,462 procedures - a 5% rise from 2023. Thus, the surge in cosmetic surgeries is boosting the photomedicine market.

Leading firms in the photomedicine market are innovating with tools like light-emitting diode (LED) devices to heighten efficacy and tackle broader medical and aesthetic needs. Light-emitting diode (LED) devices are contact-free systems emitting targeted light spectra to spark cellular activity and aid healing, commonly used in photomedicine for recovery, pain relief, skin renewal, and therapies. For instance, in April 2024, Bestqool, a US red light therapy provider, released a device for eczema management. It harnesses precise wavelengths to ease itch, puffiness, and irritation, fostering skin repair side-effect-free. This non-pharma approach yields notable symptom gains in trials.

In July 2023, Alma, an Israel-based energy-based aesthetic and medical solutions firm, acquired PhotonMed International Limited for $40 million. This deal extends Alma's footprint in aesthetics and devices, enriching its offerings with intuitive, advanced tools for health and beauty care. PhotonMed International Limited is a Hong Kong company pioneering photonics for medical devices.

Major companies operating in the photomedicine market are BIOLASE Inc., Lumenis Ltd., Candela Medical Inc., Fotona d.o.o., IRIDEX Corporation, PhotoCure ASA, Clinuvel Pharmaceuticals Limited, Erchonia Lasers Limited, Biolitec biomedical technology GmbH, Lynton Lasers Limited, Aspen Laser Systems LLC, Carl Zeiss AG, LightStim LLC, PhotoMedex Inc., Quanta Systems Ltd., THOR Photomedicine Limited.

North America was the largest region in the photomedicine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the photomedicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the photomedicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have impacted the photomedicine market by increasing the cost of imported LEDs, lasers, full-spectrum light systems, and other phototherapy devices. Segments like lasers and polychromatic polarized light systems are most affected, particularly in regions such as North America and Europe, which rely on imports for advanced equipment. While tariffs have led to higher costs and slowed adoption, they have also encouraged local manufacturing, innovation in cost-effective photomedicine solutions, and investment in domestic R&D capabilities.

The photomedicine market research report is one of a series of new reports that provides photomedicine market statistics, including photomedicine industry global market size, regional shares, competitors with a photomedicine market share, detailed photomedicine market segments, market trends and opportunities, and any further data you may need to thrive in the photomedicine industry. This photomedicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Photomedicine is a branch of medicine that leverages light-based technologies to diagnose, treat, and manage a variety of medical conditions. By utilizing specific wavelengths of light, photomedicine can stimulate biological responses, target and eliminate harmful cells, and promote tissue regeneration. These therapies are often non-invasive or minimally invasive, allowing for precise treatments with reduced side effects and faster recovery times.

The main types of photomedicine include light-emitting diodes (LEDs), lasers, full-spectrum light, polychromatic polarized light, dichroic lamps, and fluorescent lamps. Light-emitting diodes (LEDs) are gentle, non-invasive light sources that emit targeted wavelengths to activate cellular processes and support therapeutic healing. Photomedicine finds applications across a wide range of fields, including oncology, dermatology, pain management, dental procedures, aesthetics, ophthalmology, and others. The primary end users of photomedicine technologies include hospitals and clinics, dermatology and ophthalmology centers, home-based therapy setups, and research and academic institutions.

The photomedicine market consists of revenues earned by entities providing services such as light-based diagnostics, skin rejuvenation, low-level light therapy, and photodynamic therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The photomedicine market also includes sales of intense pulsed light systems, optical sensors, and phototherapy systems. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.